Research
Moffitt Cancer Center's impact on cancer research spans basic science, prevention and clinical research with a focus on translating discoveries into better care.
We are consistently striving to be the leader in understanding the complexity of cancer through team science and applying those insights directly to the patient’s bedside. Moffitt employs about 800 research faculty scientists, career staff scientists, postdocs, graduate students and support staff dedicated to cancer research.
Moffitt is proud to be one of only 51 National Cancer Institute (NCI) designated cancer centers in the country and the only one NCI-designated Comprehensive Cancer Center based in Florida. NCI designation is the highest recognition of quality cancer research spanning population, basic and translational sciences.
To read more about our research disciplines or to find a researcher, visit our Research section.
About Moffitt
- Enterprise Equity
- Awards & Recognition
- The Center For Digital Health
- Contact Us
- Corporate Compliance
- Executive Leadership
- Financial Information
- Government Relations
- Medical
- Moffitt Cancer Center Boards
- National Comprehensive Cancer Network (NCCN)
- NCI Designation
- Other Collaborations
-
Outcomes
- Bladder Cancer
- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Hodgkin Lymphoma
- Kidney and Renal Pelvis Cancer
- Larynx Cancer
- Liver and Intrahepatic Bile Duct Cancer
- Lung and Bronchial Cancer
- Melanoma
- Mesothelioma
- Non-Hodgkin Lymphoma
- Oral Cavity/Pharynx Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Soft Tissue (including Heart) Cancer
- Stomach Cancer
- Testicular Cancer
- Thyroid Cancer
- Research
- Strategic Alliances and Partnerships
- Supplier | Vendor Information
- The ReMissions